dc.contributor.author |
Musayeva N.B., Islamova Z.S. |
|
dc.date.accessioned |
2023-05-07T18:08:30Z |
|
dc.date.available |
2023-05-07T18:08:30Z |
|
dc.date.issued |
2023-04 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/7644 |
|
dc.description.abstract |
At the same time, according to the results of the study, the antithrombin
potential of the blood increases with the progression of the disease, which can be
considered as a consequence of the anti-inflammatory effect of prolonged
immunosuppressive therapy and a decrease in the exudative component in the
evolution of the disease. The increase in antithrombin potential, according to our
data, does not include the activation of antithrombin III, which requires a study to
clarify the involvement of other natural anticoagulants in the formation of
increased antithrombin activity in the blood of RA patients |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR |
en_US |
dc.relation.ispartofseries |
№2; |
|
dc.subject |
Hemostatic disorders,rheumatoid arthritis, Wilcoxon-Mann-Whitney,Spearman's rank |
en_US |
dc.title |
Hemostasiological changes in rheumatoid arthritis |
en_US |
dc.type |
Thesis |
en_US |